As a receptor tyrosine kinase of insulin receptor (IR) subfamily, anaplastic lymphoma kinase (ALK), has been validated to play important roles in various cancers, especially in non–small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL). This evidence concerns the gene ALK and non-small cell lung carcinoma.